Supplier info centre > Related news headlines
All news headlines forBiofocus DPISee also : Supplier info centre | All products for Biofocus DPI |
 |
Preclinical services news in brief
03-Jul-2008 - In this week's review of activity within the preclinical research services arena, news has emerged involving Charles River Laboratories, Galapagos and AstraZeneca.
Preclinical services news in brief
12-May-2008 - In this week's review of activity within the preclinical research services arena, news has emerged involving Galapagos, Evotec and Caliper Life Sciences.
Pharmaceutical outsourcing: people on the move
21-Apr-2008 - Galapagos, BioReliance, Parexel, MDS Pharma Services and PharmEng have all had people on the move in the world of pharmaceutical outsourcing.
BioFocus DPI launches new drug discovery platform
10-Apr-2008 - BioFocus DPI, a subsidiary of Galapagos, has launched a new platform for drug discovery at the Society for Biomolecular Sciences Annual Conference taking place this week in St Louis.
Galapagos loss widens in '07 as R&D escalates
10-Mar-2008 - Galapagos has watched its loss widen over the past year as it stepped up its internal research and development activities.
Preclinical services news in brief
06-Mar-2008 - In this week's review of activity within the preclinical research services arena, news has emerged involving Althea Technologies, Tepnel and BioFocus DPI.
Galapagos sees profit drop on spend hike; inks AZ contract
08-Aug-2007 - Galapagos has reported a profit erosion for the first half of 2007 amidst accelerated R&D spend and business reshuffling. Meanwhile its services division has inked its third contract with AstraZeneca.
Galapagos inks cancer research contract with UK University
21-Feb-2007 - Galapagos has inked a drug discovery contract with the University of Bristol in which the firm will provide services to help the university accelerate its anti-cancer research programme.
Amgen evolve Galapagos collaboration
04-Jan-2007 - Galapagos will continue to feed Amgen's drug discovery programmes having expanded the long-standing partnership between the two companies.
Galapagos buys into improved drug discovery
07-Dec-2006 - Galapagos is to spend up to €19.1m to acquire Inpharmatica in order to accelerate their drug discovery capabilities, especially in the early stages of development.
Galapagos wins grant for cystic fibrosis programme
27-Nov-2006 - The search for novel drug targets for cystic fibrosis received a boost after Dutch biotechnology company Galapagos announced the extension of its alliance with Cystic Fibrosis Foundation Therapeutics (CFFT), the non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation.
Galapagos announces first natural compound collaboration
02-Nov-2006 - Genomics-based drug discovery company Galapagos, has struck a deal with LEO Pharma in an agreement that will see the firm use its natural compound collection for high throughput screening, hit verification, and profiling of selected compounds for LEO Pharma's antibacterial research program.